Beyond animal models toward true human relevance

Ananda Devices hires Life Science industry expert as new CEO to lead business expansion for innovative NAM technology

DOVER, DE, UNITED STATES, September 11, 2026 /EINPresswire.com/ -- Ananda Devices is a technology innovator and leading supplier in the emerging New Approach Methodologies (NAMs) segment of the Life Sciences market. Founded by Dr. Margaret Magdesian, Ananda Devices designs, develops and manufactures microphysiological systems (MPS) that provide more predictive human neuronal models to accelerate discovery. As market demand for NAMs increases, Ananda plans to expand operations to the United States and is happy to announce that effective immediately Dr. Olson will join the executive management team as CEO and Dr. Magdesian will transition to the role of CSO. Dr Magdesian stated, “Adding Keith to the executive leadership team will provide the commercial and executive leadership experience we need to take the company to the next level and allows me the time to focus on advancing our dual-use technology even further”.

Dr. Olson brings decades of Life Science expertise through leadership roles in a variety of organizations including Corning, Fujifilm and Life Technologies. He has broad experience commercializing advanced cell-based products and has led teams that have launched over 700 products and services. “Ananda Devices has developed highly relevant solutions that have rapidly gained market traction due to their superior ease of use, sensitivity and flexibility”, stated Dr. Olson. “I am honored to join the team and confident that our human-relevant systems will make our clients more successful and more efficient in their discovery efforts.”

“We are thrilled to add Keith to our team and provide us with the expertise needed to take the company from technology innovator to commercial success”, stated Dr. Roger Bosse, chairman of the board for Ananda Devices. “Our goal has always been to advance MPS technologies that accelerate toxin evaluation and therapeutic development, reduce reliance on animal models and deliver more predictive data for faster, safer, and more effective treatments. With growing momentum in the U.S. this is a pivotal moment to support companies adopting and transitioning to NAMs.”

Ananda Devices is now poised to execute on their key strategic objectives: global expansion of product sales, manufacturing expansion in the United States and delivery of advanced cell biology solutions across multiple market segments.

About Ananda Devices:
Ananda Devices develops human-relevant MPS solutions that replicate neuromuscular and neuronal physiology, enabling predictive preclinical data generation aligned with New Approach Methods (NAMs) and the FDA Modernization Act. Founded in 2016 as a spinout from McGill University, Ananda Devices is a seed stage company based in Laval, Quebec focused on improving model systems in neuroscience for drug discovery, disease modeling, toxin testing, food safety and development of medical countermeasures. Ananda provides both products and services and our two lead products, NeuroHTS™ and NeuroMuscle™, were launched at the beginning of 2026.

Keith Olson
Ananda Devices
+1 607-684-3419
contact@anandadevices.com
Visit us on social media:
LinkedIn